Document Detail

Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants.
MedLine Citation:
PMID:  12607719     Owner:  NLM     Status:  MEDLINE    
The use of cardiopulmonary bypass is still necessary for the repair of many congenital cardiac defects. However, exposure to cardiopulmonary bypass can still lead to major morbidity and sometimes mortality, especially in neonates and infants, despite a perfect surgical repair. Various research-based strategies have been used to minimize some of the complications related to cardiopulmonary bypass, including the systemic inflammatory response, hemodilution, and transfusion requirement. This overview provides some of the strategies that we use in our practice in applying cardiopulmonary bypass in the repair of congenital cardiac defects in neonates and infants.
Irving Shen; Carmen Giacomuzzi; Ross M Ungerleider
Related Documents :
14745929 - Trend in prevalence of neural tube defects in quebec.
10770089 - Neural tube defects in turkey: prevalence, distribution and risk factors.
2061799 - The changing incidence of neural tube defects in scotland.
12607719 - Current strategies for optimizing the use of cardiopulmonary bypass in neonates and inf...
18972209 - Birth defects and genetic disorders among arab americans--michigan, 1992-2003.
2480859 - Towards the prevention of neural tube defects.
9481059 - Etiology and outcome of hydrops fetalis.
23586439 - Specific-pathogen-free status is associated with lower infant mortality rate in rhesus ...
6848309 - Potentiation of magnesium-induced neuromuscular weakness by gentamicin.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  75     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-27     Completed Date:  2003-03-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S729-34     Citation Subset:  AIM; IM    
Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon 97201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aprotinin / therapeutic use
Cardiopulmonary Bypass* / instrumentation,  methods
Heart Arrest, Induced
Heart Defects, Congenital / surgery*
Hemostasis, Surgical
Hemostatics / therapeutic use
Infant, Newborn
Postoperative Period
Reg. No./Substance:
0/Hemostatics; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapy with insulin in cardiac surgery: controversies and possible solutions.
Next Document:  Aprotinin and preservation of myocardial function after ischemia-reperfusion injury.